On 6 May at Vitalis, a dedicated session will focus on the path from innovation to structured introduction of medical technology products in cancer care.
Who is involved: healthcare, authorities, decision-makers, and companies.
What the session will cover:
-
Evidence: what is needed to support adoption.
-
Implementation: how solutions are introduced in practice.
-
National decisions: how decisions are made at a national level.
The session positions medical technology as a potential contributor to patient benefit in a care area described as having major needs and limited resources.
